We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
326
Pacific Biosciences
PACB
$444M
$7.17M 0.05%
280,431
– –
DBX icon
327
Dropbox
DBX
$7.76B
$7.05M 0.05%
241,194
+56,687
+31% +$1.76M
GIS icon
328
General Mills
GIS
$20.3B
$6.96M 0.05%
116,416
-96,623
-45% -$5.71M
HUM icon
329
Humana
HUM
$43.3B
$6.93M 0.05%
17,808
+5,179
+41% +$2.2M
HBAN icon
330
Huntington Bancshares
HBAN
$34.5B
$6.85M 0.05%
443,021
-298,750
-40% -$4.4M
FMTX
331
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$6.79M 0.05%
292,692
– –
BEAM icon
332
Beam Therapeutics
BEAM
$2.76B
$6.71M 0.05%
77,147
– –
KRTX
333
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$6.7M 0.05%
54,750
– –
XYZ
334
Block Inc
XYZ
$49.6B
$6.66M 0.05%
27,783
+1,379
+5% +$354K
ICE icon
335
Intercontinental Exchange
ICE
$87.3B
$6.64M 0.05%
57,815
-19,047
-25% -$2.26M
COO icon
336
Cooper Companies
COO
$14.2B
$6.63M 0.05%
+64,192
New +$6.85M
PSNL icon
337
Personalis
PSNL
$1.27B
$6.58M 0.04%
341,867
+20,000
+6% +$418K
URI icon
338
United Rentals
URI
$66.9B
$6.58M 0.04%
18,738
+2,501
+15% +$840K
COP icon
339
ConocoPhillips
COP
$143B
$6.56M 0.04%
96,857
-1,429
-1% -$82.5K
JKHY icon
340
Jack Henry & Associates
JKHY
$11.5B
$6.56M 0.04%
40,001
-7,083
-15% -$1.22M
VNE
341
DELISTED
Veoneer, Inc.
VNE
$6.55M 0.04%
+192,470
New +$6.12M
BHVN
342
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$6.53M 0.04%
47,005
– –
AVY icon
343
Avery Dennison
AVY
$12.8B
$6.49M 0.04%
31,341
– –
NOMD icon
344
Nomad Foods
NOMD
$1.76B
$6.38M 0.04%
231,587
+119,543
+107% +$3.24M
MAC icon
345
Macerich
MAC
$7.54B
$6.36M 0.04%
+380,634
New +$6.46M
LDL
346
DELISTED
Lydall, Inc.
LDL
$6.33M 0.04%
101,884
+2,686
+3% +$165K
SC
347
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$6.32M 0.04%
+151,457
New +$6.23M
DELL icon
348
Dell
DELL
$245B
$6.3M 0.04%
119,406
+28,263
+31% +$1.41M
DSPG
349
DELISTED
DSP Group Inc
DSPG
$6.27M 0.04%
+286,076
New +$5.11M
GTS
350
DELISTED
Triple-S Management Corporation
GTS
$6.23M 0.04%
+176,192
New +$5.03M
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.